Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-14

FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron tablets from Actavis Pharma, Inc. under the ANDA, signifying an approved change to this generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)